Financial & competing interests disclosure
Honoraria as consultant and as Speaker bureau member for Roche Eli-Lilly and AstraZeneca. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.